Literature DB >> 21654699

Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability.

Marijke De Bock1, Maxime Culot, Nan Wang, Mélissa Bol, Elke Decrock, Elke De Vuyst, Anaelle da Costa, Ine Dauwe, Mathieu Vinken, Alexander M Simon, Vera Rogiers, Gaspard De Ley, William Howard Evans, Geert Bultynck, Geneviève Dupont, Romeo Cecchelli, Luc Leybaert.   

Abstract

The cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) is an important factor determining the functional state of blood-brain barrier (BBB) endothelial cells but little is known on the effect of dynamic [Ca(2+)](i) changes on BBB function. We applied different agonists that trigger [Ca(2+)](i) oscillations and determined the involvement of connexin channels and subsequent effects on endothelial permeability in immortalized and primary brain endothelial cells. The inflammatory peptide bradykinin (BK) triggered [Ca(2+)](i) oscillations and increased endothelial permeability. The latter was prevented by buffering [Ca(2+)](i) with BAPTA, indicating that [Ca(2+)](i) oscillations are crucial in the permeability changes. Bradykinin-triggered [Ca(2+)](i) oscillations were inhibited by interfering with connexin channels, making use of carbenoxolone, Gap27, a peptide blocker of connexin channels, and Cx37/43 knockdown. Gap27 inhibition of the oscillations was rapid (within minutes) and work with connexin hemichannel-permeable dyes indicated hemichannel opening and purinergic signaling in response to stimulation with BK. Moreover, Gap27 inhibited the BK-triggered endothelial permeability increase in in vitro and in vivo experiments. By contrast, [Ca(2+)](i) oscillations provoked by exposure to adenosine 5' triphosphate (ATP) were not affected by carbenoxolone or Gap27 and ATP did not disturb endothelial permeability. We conclude that interfering with endothelial connexin hemichannels is a novel approach to limiting BBB-permeability alterations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654699      PMCID: PMC3185887          DOI: 10.1038/jcbfm.2011.86

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  54 in total

1.  In vitro model for evaluating drug transport across the blood-brain barrier.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  The type 3 inositol 1,4,5-trisphosphate receptor is concentrated at the tight junction level in polarized MDCK cells.

Authors:  Pascal Colosetti; Richard E A Tunwell; Caroline Cruttwell; Jean-Pierre Arsanto; Jean-Pierre Mauger; Doris Cassio
Journal:  J Cell Sci       Date:  2003-05-20       Impact factor: 5.285

Review 3.  The gap junction cellular internet: connexin hemichannels enter the signalling limelight.

Authors:  W Howard Evans; Elke De Vuyst; Luc Leybaert
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

4.  Cx37 and Cx43 localize to zona pellucida in mouse ovarian follicles.

Authors:  Alexander M Simon; Hwudaurw Chen; Charity L Jackson
Journal:  Cell Commun Adhes       Date:  2006 Jan-Apr

Review 5.  Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system.

Authors:  Christian Giaume; Martin Theis
Journal:  Brain Res Rev       Date:  2009-12-04

6.  An electrophysiological study of microvascular permeability and its modulation by chemical mediators.

Authors:  S P Olesen
Journal:  Acta Physiol Scand Suppl       Date:  1989

7.  Transcellular gaps in microvascular walls of frog and rat when permeability is increased by perfusion with the ionophore A23187.

Authors:  C R Neal; C C Michel
Journal:  J Physiol       Date:  1995-10-15       Impact factor: 5.182

8.  Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema.

Authors:  Madeleine Austinat; Stefan Braeuninger; João B Pesquero; Marc Brede; Michael Bader; Guido Stoll; Thomas Renné; Christoph Kleinschnitz
Journal:  Stroke       Date:  2008-11-06       Impact factor: 7.914

9.  Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model.

Authors:  E Decrock; E De Vuyst; M Vinken; M Van Moorhem; K Vranckx; N Wang; L Van Laeken; M De Bock; K D'Herde; C P Lai; V Rogiers; W H Evans; C C Naus; L Leybaert
Journal:  Cell Death Differ       Date:  2008-09-26       Impact factor: 15.828

10.  Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells.

Authors:  Katleen Braet; Sandrine Aspeslagh; Wouter Vandamme; Klaus Willecke; Patricia E M Martin; W Howard Evans; Luc Leybaert
Journal:  J Cell Physiol       Date:  2003-11       Impact factor: 6.384

View more
  57 in total

1.  Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease.

Authors:  Odunayo O Mugisho; Colin R Green; David M Squirrell; Sarah Bould; Helen V Danesh-Meyer; Jie Zhang; Monica L Acosta; Ilva D Rupenthal
Journal:  J Mol Med (Berl)       Date:  2018-12-08       Impact factor: 4.599

Review 2.  Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain.

Authors:  Marijke De Bock; Luc Leybaert; Christian Giaume
Journal:  Neurochem Res       Date:  2017-06-20       Impact factor: 3.996

Review 3.  Intercellular Ca(2+) waves: mechanisms and function.

Authors:  Luc Leybaert; Michael J Sanderson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

4.  High bone mass in mice lacking Cx37 because of defective osteoclast differentiation.

Authors:  Rafael Pacheco-Costa; Iraj Hassan; Rejane D Reginato; Hannah M Davis; Angela Bruzzaniti; Matthew R Allen; Lilian I Plotkin
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

Review 5.  Transient receptor potential channels and regulation of lung endothelial permeability.

Authors:  Patricia C Villalta; Mary I Townsley
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

6.  Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure.

Authors:  Allison M Johnson; James P Roach; Anna Hu; Svetlana M Stamatovic; Michal R Zochowski; Richard F Keep; Anuska V Andjelkovic
Journal:  FASEB J       Date:  2018-01-02       Impact factor: 5.191

Review 7.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

8.  Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia.

Authors:  Martin Krueger; Ingo Bechmann; Kerstin Immig; Andreas Reichenbach; Wolfgang Härtig; Dominik Michalski
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-26       Impact factor: 6.200

9.  Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevation.

Authors:  Nan Wang; Marijke De Bock; Gudrun Antoons; Ashish K Gadicherla; Mélissa Bol; Elke Decrock; William Howard Evans; Karin R Sipido; Feliksas F Bukauskas; Luc Leybaert
Journal:  Basic Res Cardiol       Date:  2012-10-21       Impact factor: 17.165

10.  Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.

Authors:  Yeri Kim; Jarred M Griffin; Mohd N Mat Nor; Jie Zhang; Peter S Freestone; Helen V Danesh-Meyer; Ilva D Rupenthal; Monica Acosta; Louise F B Nicholson; Simon J O'Carroll; Colin R Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.